valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

TETRA TECHNOLOGIES INC (TTI) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$1.40 ComplexityHigh Updated
-$0.12 $5.23
bear -$0.12 base $3.04 bull $5.23 margin of safety $1.40 market price* $5.32
TETRA Technologies has two businesses. The larger and more profitable is Completion Fluids & Products: clear brine fluids, including the proprietary TETRA Neptune line, sold for deepwater well completions in the Gulf of America, the North Sea, Brazil and the Middle East, plus calcium chloride plants in the United States and northern Europe and an ultra-pure zinc bromide (TETRA PureFlow) battery electrolyte sold to Eos Energy under a preferred supply agreement that runs through December 31, 2027. The smaller, more commoditized business is Water & Flowback Services for US onshore shale, which lost money in 2025 as US activity fell. The company today is not the company of a decade ago: it gave up its compression subsidiary at the start of 2021 and had already left offshore services, so we measure it only from 2021 onward. Earnings level. We measure owner earnings as operating cash flow, stripped of working-capital swings, minus stock compensation and the spending needed to keep the existing plant and fleet running. Every dollar spent on the Arkansas bromine plant is treated as investment in a new business, not as upkeep. Before interest, the existing business produced roughly $0, $27M, $46M, $31M and $48M of cash in 2021 through 2025. The 2025 operating cash flow of $100M looks much better than that, but about $32M of it came from collecting receivables and stretching payables, and we strip that out. We use the median of these five years, about $31M a year (about $0.21 per share). The window covers a trough (2021, coming out of the shutdown) and two strong deepwater years, so it is a fair middle of the cycle. Owner earnings rose sharply in 2025, so assuming no growth in the existing business for 2027 is well below the most recent year's actual pace. The first half of 2026 supports this level rather than a higher one: operating cash flow was only $23M, held back by a receivables build, and the company says the timing of Neptune jobs could swing the second half. What it owes. At June 30, 2026 the company had a $190M term loan due January 1, 2030, about $1M of Argentine borrowings and $3M of finance leases, against $155M of cash. Most of that cash came from selling about 12.4 million new shares at $9.25 in June 2026, and it is earmarked for the bromine plant. The term loan floats at SOFR plus 5.75%, roughly 10% today. That is costly debt, and we count its extra cost until 2030 (about $21M) as part of what is owed. Net of working cash, the company owes roughly $80M. The loan requires leverage no higher than 4 times and at least $50M of liquidity at all times. The bromine plant. The board approved the Arkansas bromine plant on May 28, 2026, on the Evergreen Brine Unit with an ExxonMobil subsidiary as partner. About $220M of spending remained at March 31, with first production expected in early 2028. The plant's purpose is to replace bromine that TETRA now buys from LANXESS under a long-term contract, plus bridging supply through 2027. Initial output is planned at about 25% above that contracted volume. This is capacity under construction feeding the company's own demand, so we credit it. We do not credit the later doubling to nameplate, lithium, or the proposed magnesium joint venture with Magrathea; none is contracted or funded. We also give no value to growth in Eos electrolyte volumes beyond today's level, because Eos has not yet reached its stated production targets. Base case. The existing businesses stay at about $31M a year before interest, with no growth, for roughly thirty years. Calcium chloride plants and the completion-fluids franchise have operated for decades, so that life is supported. The bromine plant costs about $50M more in late 2026 and $140M in 2027, starts up in 2028, and then saves about $25M a year in bromine purchase costs through the early 2050s. On that path the operating business is worth about $447M, the plant adds a net $90M after its remaining cost, and after about $80M owed the shares are worth about $3.04 each. Bear case. Deepwater completions and US shale activity have collapsed together before, in the 2015-2016 oil price collapse and again in the 2020 shutdown. In 2020-2021 this business's cash before interest fell to roughly zero. We repeat that in 2027-2028: cash before interest of $5M and then nothing, against interest of about $17M a year. The trough lands while the plant is still being built, and we assume a cost overrun of about $60M. We also assume first-of-a-kind start-up problems hold its savings to about $8M a year. The business recovers only to about $25M a year. The company would have to raise more money at depressed prices, and refinancing the 2030 loan would cost more, which adds about $35M to what is owed. In this case the business is worth about $280M, the plant destroys about $180M, and the debt takes the rest: shareholders are left with slightly less than nothing, about $0.12 per share in the red, or roughly $18M. Bull case. The existing businesses run at about $42M a year before interest, close to the 2023 and 2025 levels, supported by the Beacon Offshore three-well Neptune Z-Lite program already awarded and the Eos electrolyte supply already contracted. The plant starts on time and saves about $40M a year by fully displacing purchased bromine at integrated cost. The business is worth about $598M, the plant adds about $269M, and after the debt the shares are worth about $5.23. Accounting judgements. Large non-cash items are excluded from the earnings level: a $94M tax benefit from releasing a valuation allowance in 2024, a $9.5M currency charge from closing a Canadian subsidiary in 2025, and the 2021 gain on selling the compression business. Arkansas pre-development costs that were expensed in 2022-2023, before any capital was spent, remain inside the earnings history, which slightly understates the existing business. Margin-of-safety price. We are only moderately sure of the $31M earnings level. It sits in the middle of a five-year range running from zero to $48M, and the business swings with offshore drilling, shale activity and a handful of large deepwater jobs. The worst plausible outcome is the bear case: an oil downturn while the company is still spending about $190M on a plant that has never run. The new equity and the cash pile give it a cushion, but not enough to finish the plant and service a 10% loan through two lean years without raising more money. If we are wrong about the plant's savings and the downturn timing, the shares are worth roughly nothing. If we are wrong only about the plant, the existing business alone is worth a little over $1 a share. The company pays no dividend, so any return has to come from the business. The estimate depends on the plant running and the existing business holding its level, which will take three to four years. At $1.40, the price is about what the existing operations are worth on their own, with no value assigned to the plant. If the base case plays out over that period, the implied return exceeds 20% a year; if the plant fails, the shares are worth roughly nothing. The margin-of-safety price is $1.40.
Fiscal yearOwner's earningsMethodology
2025 $0.23 ▼
Recomputed on the current basis (prior row used CFO - total capex - SBC). OE = CFO - dWC - SBC - maintenance capex. CFO=$100,360K; dWC cash effect=+$32,495K (AR +5,785; inventories -9,656; prepaid +101; payables/accrued +27,426; other +8,839); SBC=$7,094K; capex=$80,821K, of which $49,700K was the Arkansas bromine plant (45,200 net of partner reimbursement plus 4,500 capitalized interest), classified wholly as growth capex; remaining capex $31,121K; capex ratio 5.95%; revenue rose $31,821K ($599.1M to $630.9M) so formula growth capex=$1,893K and maintenance capex=$29,228K; OE=$31,543K; diluted shares=135,150K; OE/sh=$0.2334. Reconciliation: NI 2,998 + D&A 37,099 + deferred tax 8,427 + 9,516 non-cash Canadian CTA loss + other non-cash (incl. SBC) = CFO before WC 67,865, ties. Interest paid $16,819K. Source: FY2025 10-K, accession 0000844965-26-000015.
2024 $0.07 ▼
Recomputed on the current basis (prior row used CFO - total capex - SBC). OE = CFO - dWC - SBC - maintenance capex. CFO=$36,520K; dWC cash effect=-$16,830K (AR +5,702; inventories -8,784; prepaid -6,574; payables/accrued -4,140; other -3,034); SBC=$6,572K; capex=$60,680K, of which $23,600K was the Arkansas bromine plant (22,400 net of partner reimbursement plus 1,200 capitalized interest) - a new business under construction, classified wholly as growth capex; remaining capex $37,080K; revenue declined ($626.3M to $599.1M) so formula growth capex=$0 and maintenance capex=$37,080K; OE=$9,698K; diluted shares=132,231K; OE/sh=$0.0733. Reconciliation: NI 108,280 + D&A 35,721 - deferred tax benefit 94,455 (valuation-allowance release) + other non-cash = CFO before WC 53,350, ties. Interest paid $21,680K. Source: FY2025 10-K, accession 0000844965-26-000015.
2023 $0.21 ▼
Recomputed on the current basis (prior row used CFO - total capex - SBC). OE = CFO - dWC - SBC - maintenance capex. CFO=$70,206K; dWC cash effect=-$1,270K (AR +20,165; inventories -23,205; prepaid +2,176; payables/accrued -128; other -278); SBC=$10,622K; capex=$38,152K (no capitalized Arkansas spend; 12,119 of Arkansas pre-development expensed inside CFO, offset by 9,300 partner reimbursement); capex ratio 5.95%; revenue rose $73,049K ($553.2M to $626.3M) so growth capex=$4,345K and maintenance capex=$33,807K; OE=$27,047K; diluted shares=131,243K; OE/sh=$0.2061. Reconciliation: NI 25,757 + D&A 34,329 + other non-cash (incl. SBC) = CFO before WC 71,476, ties. Interest paid $19,171K. Source: FY2025 10-K, accession 0000844965-26-000015.
2022 $0.09 ▼
Recomputed on the current basis (prior row used CFO - total capex - SBC). OE = CFO - dWC - SBC - maintenance capex. CFO=$18,957K; dWC cash effect=-$29,715K (AR -39,848; inventories -4,471; prepaid -4,546; payables/accrued +22,705; other -3,555); SBC=$6,880K; capex=$40,056K (no Arkansas capital; 6,635 of Arkansas pre-development was expensed inside CFO); capex ratio 5.95%; revenue rose $164,941K ($388.3M to $553.2M) so growth capex=$9,812K and maintenance capex=$30,244K; OE=$11,548K; diluted shares=129,778K; OE/sh=$0.0890. Reconciliation: NI 7,796 + D&A 32,819 + other non-cash (incl. SBC 6,880, impairments 2,804) = CFO before WC 48,672, ties. Interest paid $15,669K. Source: FY2024 10-K, accession 0000844965-25-000013.
2021 -$0.11 ▼
Recomputed on the current basis (prior row used CFO - total capex - SBC, a superseded formula; whole series recomputed). OE = CFO - dWC - SBC - maintenance capex. CFO=$4,657K; dWC cash effect=-$5,483K (AR -27,795; inventories +5,387; prepaid -6,533; payables/accrued +27,006; other -3,548); SBC=$4,664K; capex=$20,533K (no Arkansas capital); capex ratio 5.95% (mean non-Arkansas capex/revenue 2021-2025); revenue rose $10,557K (2020 $377.7M to 2021 $388.3M) so growth capex=$628K and maintenance capex=$19,905K; OE=-$14,429K; diluted shares=126,602K; OE/sh=-$0.1140. Reconciliation: NI 103,602 + D&A 33,532 - disposal gain 120,137 - Standard Lithium gain 15,479 + other non-cash (incl. SBC) = CFO before WC 10,140, ties to the filer's reconciliation. Compression deconsolidated 2021-01-31, so CFO holds one month of that business; post-pandemic trough year. Interest paid $14,347K. Source: FY2023 10-K, accession 0000844965-24-000020; FY2022 10-K 0000844965-23-000009.
2020 $0.18 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$76,912K (statement combines continuing and discontinued Compression operations); dWC cash effect=+$17,915K (AR +62,569; inventories +16,983; prepaid +1,672; payables/accrued -62,274; other -1,035); SBC=$6,616K; capex=$29,386K, revenue declined (continuing $561.2M to $377.7M) so growth capex=$0 and maintenance capex=$29,386K; OE=$22,995K; diluted shares=125,838K; OE/sh=$0.1827. Reconciliation: NI -98,933 + D&A 118,747 + other non-cash 39,183 (incl. SBC 6,616, impairments 20,940) = 58,997 = CFO before WC, ties. Pandemic year and last year of CSI Compressco consolidation - outside valuation window. Interest paid $63,935K. Source: FY2022 10-K, accession 0000844965-23-000009.
2019 -$0.05 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$90,232K; dWC cash effect=-$16,523K (AR +6,471; inventories -2,770; prepaid +579; payables/accrued -16,545; other -4,258); SBC=$8,127K; capex=$108,273K; capex ratio 8.7%; revenue growth $39,158K ($998.8M to $1,037.9M consolidated) so growth capex=$3,407K and maintenance capex=$104,866K; OE=-$6,238K; diluted shares=125,600K; OE/sh=-$0.0497. Includes consolidated CSI Compressco - outside valuation window. Interest paid $68,332K. Source: FY2019 10-K, accession 0000844965-20-000002.
2018 -$0.34 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$46,586K; dWC cash effect=-$36,766K (AR -5,512; inventories -29,221; prepaid -3,888; payables/accrued +5,463; other -3,608); SBC=$7,379K; capex=$141,931K (largely CSI Compressco compressor fleet growth); capex ratio 8.7%; revenue growth $275,677K ($723.1M to $998.8M consolidated) so growth capex=$23,984K and maintenance capex=$117,947K; OE=-$41,974K; diluted shares=124,101K; OE/sh=-$0.3382. Includes consolidated CSI Compressco - different business, outside valuation window. Interest paid $56,261K. Source: FY2019 10-K, accession 0000844965-20-000002.
2017 $0.22 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$64,595K; dWC cash effect=-$10,540K (AR -55,197; inventories -11,332; prepaid -1,608; payables/accrued +58,937; other -1,340; decommissioning spend 565 kept as operating cost); SBC=$7,727K; capex=$51,923K; capex ratio 8.7% (mean capex/revenue 2016-2019 consolidated era); revenue growth $105,707K (2016 $617.4M to 2017 $723.1M, same basis FY2018 10-K) so growth capex=$9,197K and maintenance capex=$42,726K; OE=$24,682K; diluted shares=114,499K; OE/sh=$0.2156. Includes consolidated CSI Compressco (deconsolidated Jan 2021) - different business, outside valuation window. Interest paid $46,286K. Source: FY2017 10-K, accession 0000844965-18-000004.
2016 $0.07 ▼
OE = CFO - dWC - SBC - maintenance capex (current basis; whole series recomputed because prior rows used CFO - total capex - SBC). CFO=$55,659K (restated, FY2017 10-K); dWC cash effect=+$14,477K (AR +64,331; inventories +1,384; prepaid +3,348; payables/accrued -54,092; other -494; decommissioning-liability spend of 4,040 treated as an operating cost, not working capital); SBC=$13,747K; capex=$21,066K, revenue declined (2015 $1,130.1M to 2016 $694.8M) so growth capex=$0 and maintenance capex=$21,066K; OE=$6,369K; diluted shares=87,286K; OE/sh=$0.0730. Reconciliation: NI + D&A + other non-cash items - maintenance capex ties to OE exactly (CFO before WC is the filer's own reconciliation). Period consolidated CSI Compressco and the offshore business, so it describes a different company than today's and is excluded from the valuation window. Interest paid $54,506K. Source: FY2017 10-K, accession 0000844965-18-000004; FY2016 10-K 0000844965-17-000003.
2015 $0.66 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$197,002K (restated, FY2017 10-K); dWC cash effect=+$12,182K (AR +38,025; inventories +70,431; prepaid -1,806; payables/accrued -97,356; other +2,888; decommissioning-liability spend of 10,305 kept as an operating cost); SBC=$16,887K; capex=$120,597K; capex ratio 8.7% (mean capex/revenue, consolidated era); revenue rose $52,578K (2014 $1,077.6M to 2015 $1,130.1M) so growth capex=$4,574K and maintenance capex=$116,023K; OE=$51,910K; diluted shares=79,169K; OE/sh=$0.6557. Consolidated CSI Compressco and offshore era - different business, excluded from the valuation window. Interest paid $52,491K. Source: FY2017 10-K, accession 0000844965-18-000004; FY2016 10-K 0000844965-17-000003.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (South, primarily Texas, Louisiana, Oklahoma and the Gulf of America offshore; Arkansas and Tennessee for calcium chloride and electrolyte; Midwest and West for industrial calcium chloride), Europe (Sweden, Finland, Norway, United Kingdom), Latin America (Argentina, Brazil, Mexico), Middle East (Saudi Arabia, United Arab Emirates), Canada
Historical growth strategy
Grows by redeploying capital into its own niches rather than large acquisitions: it built and later sold or spun off adjacent businesses (offshore services, Maritech, CSI Compressco), then refocused on high-value completion fluids, industrial calcium chloride and specialty bromine chemistry, extending that chemistry into new end markets such as zinc-bromide battery electrolyte, and now backward-integrating into raw bromine through its Arkansas brine leases funded by operating cash, term debt and new equity.
Chart analysis
A chartist would see a long, volatile base. The shares collapsed from the high teens in the early 2010s to near a dollar during the 2020 shutdown, recovered into a choppy $3 to $6 range through 2022-2024, then broke down again toward $2 in early 2025 before a powerful breakout during 2025-2026 that carried the price well above its multi-year resistance around $6, with a secondary equity offering struck at $9.25 in June 2026. A chartist would read the breakout as a regime change in trend, but would flag that the move is steep and extended relative to the long-term moving averages, that the old resistance zone near $5 to $6 is the obvious support to watch on any pullback, and that the stock has a long history of sharp reversals after rallies.
Competitors

Companies we consider competitors of TTI. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.